Publications

Search our bibliography using the filters on the right-hand side.

Displaying 1 through 19 of 19 publications.

Krege JH, Gilsenan AW, Komacko JL, Kellier-Steele N. Teriparatide and osteosarcoma risk: history, science, elimination of boxed warning, and other label updates. J Bone Miner Res. 2022 Aug 14;6(9):e10665. doi: 10.1002/jbm4.10665

Law EH, Galve-Calvo E, Wockel A, Parikh R, Kurosky SK, Derrien Ansquer V, Frugier G, Davis KL, Esterberg E, Oikonomidou O. European treatment patterns and outcomes associated with first-line CDK4/6 inhibition and hormonal therapies assessed in a real-world non-interventional study (EUCHARIS). Poster presented at the 2021 San Antonio Breast Cancer Symposium (SABCS); December 7, 2021. San Antonio, TX. [abstract] Cancer Res. 2022 Feb 15; 82(4_Suppl):OT2-19-04. doi: 10.1158/1538-7445.SABCS21-OT2-19-04

Gilsenan A, Midkiff K, Harris D, Kellier-Steele N, McSorley D, Andrews EB. Teriparatide did not increase adult osteosarcoma incidence in a 15-year US postmarketing surveillance study. J Bone Miner Res. 2020 Feb;36(2):244-51. doi: 10.1002/jbmr.4188

Dine JL, Garimella SV, Gehlhaus K, Grandin M, Letwin D, Caplen N, Lipkowitz S. Gp78 is a negative regulator of TRAIL-induced apoptosis in breast cancer cells. Poster presented at the 106th Annual Meeting of the American Association for Cancer Research; April 2015. Philadelphia, PA. [abstract] Cancer Res. 2015 Aug; 75(15 Suppl):15. doi: 10.1158/1538-7445.AM2015-15

Samelson EJ, Miller PD, Christiansen C, Daizedeh NS, Grazette L, Anthony MS, Egbuna O, Wang A, Siddhanti SR, Cheung AM, Franchimont N, Kiel DP. RANKL inhibition with denosumab does not influence 3-year progression of aortic calcification or incidence of adverse cardiovascular events in postmenopausal women with osteoporosis and high cardiovascular risk. J Bone Miner Res. 2014 Feb;29(2):450-7. doi: 10.1002/jbmr.2043

Andrews EB, Gilsenan AW, Midkiff K, Sherrill B, Wu Y, Mann BH, Masica D. The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the first 7 years. J Bone Miner Res. 2012 Dec;27(12):2429-37. doi: 10.1002/jbmr.1768

Herring WL, Herrmann JW. The single-day surgery scheduling problem: sequential decision-making and threshold-based heuristics. OR spectrum: quantitative approaches in management. 2012 Apr 1;34(2):429-59.

Sherrill B, Amonkar MM, Sherif BN, Maltzman J, O'Rourke L, Johnston S. An exploration of the association of Quality-of-Life (QOL) scores with tumor progression status in first line hormone receptor positive, HER2+ Metastatic Breast Cancer (MBC) patients treated with lapatinib plus letrozole or letrozole alone. Poster presented at the Thirty-Second Annual CTRC‐AACR San Antonio Breast Cancer Symposium; December 2009. San Antonio, TX. [abstract] Cancer Res. 2009 Dec; 69(24 (Suppl)):5106. doi: 10.1158/0008-5472.SABCS-09-5106

Schildkraut JM, Goode EL, Clyde MA, Iversen ES, Moorman PG, Berchuck A, Marks JR, Lissowska J, Brinton L, Peplonska B, Cunningham JM, Vierkant RA, Rider DN, Chenevix-Trench G, Webb PM, Beesley J, Chen X, Phelan C, Sutphen R, Sellers TA, Pearce L, Wu AH, Den Berg DV, Conti D, Elund CK, Anderson R, Goodman MT, Lurie G, Carney ME, Thompson PJ, Gayther SA, Ramus SJ, Jacobs I, Kjaer SK, Hogdall E, Blaakaer J, Hogdall C, Easton DF, Song H, Pharoah HDP, Whittemore AS, McGuire V, Quaye L, Anton-Culver H, Ziogas A, Terry KL, Cramer DW, Hankinson SE, Tworoger SS, Calingaert B, Chanock S, Sherman M, Garcia-Closas M. Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res. 2009 Mar;69(6):2349-57.

Do T, Wade S, Anthony MS, Wagman RB, Downs RW. Medication switching in postmenopausal women on osteoporosis therapy: six-month findings from the POSSIBLE US™ Study. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; August 2008. [abstract] J Bone Miner Res. 2008 Aug 13; 23(S1):S468.

Tosteson ANA, Wade S, Anthony MS, Brancato C, Nichols S, Downs RW. Correlates of osteoporosis treatment persistence for patients new to therapy and patients with recent switches: 6-month results from POSSIBLE US. Poster presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research; August 2008. [abstract] J Bone Miner Res. 2008 Aug; 23(Suppl 1):S468.

Strader C, Shinoff CW, Fitzpatrick LA, Anthony MS. Burden of hip and wrist fractures: incidence estimates of non-traumatic fractures in older women in North America, Western Europe, Australia, and Japan. Poster presented at the 29th Annual Meeting of the American Society for Bone and Mineral Research; September 2007. [abstract] J Bone Miner Res. 2007 Sep; 22(Suppl 1):S118.

Anthony MS, Stephenson JJ, Long S, Lin SL. Low prevalence of bisphosphonate therapy among long-term glucocorticoid users. Poster presented at the 28th Annual Meeting of the American Society for Bone and Mineral Research; September 2006. Philadelphia, PA. [abstract] J Bone Miner Res. 2006 Sep; 21(Suppl 1):S281.

Wood CE, Register TC, Franke AA, Anthony MS, Cline JM. Dietary soy isoflavones inhibit estrogen effects in the postmenopausal breast. Cancer Res. 2006 Jan 15;66(2):1241-9.

Anthony MS, Bradbury BD, Satia JA. Diagnosed osteoporosis: the tip of the iceberg. Poster presented at the 27th Annual Meeting of the American Society for Bone and Mineral Research; August 2005. [abstract] J Bone Miner Res. 2005 Aug 11; 20(Suppl 1):S261.

Paramastri YA, Anthony MS, Wilkinson LM, Phifer BM, Cline JM. Dietary soy phytoestrogens inhibit tumor promotion by exogenous but not endogenous estrogens in the rat DMBA model of mammary carcinogenesis. Cancer Res. 2001 Mar;42(Suppl):310.

Register TC, Anthony MS, Jayo MJ, Williams JK. Effects of 17ß-estradiol and consumption of phytoestrogen-rich soy or casein/lactalbumin-based diets on serum chemistries in ovariectomized female macaques. Poster presented at the 19th Annual Meeting of the American Society for Bone and Mineral Research; August 1997. [abstract] J Bone Miner Res. 1997 Aug; 12(Suppl 1):S350.

Jayo MJ, Anthony MS, Register TC, Rankin SE, Vest T, Clarkson TB. Dietary soy isoflavones and bone loss: a study in ovariectomized monkeys. Poster presented at the 18th Annual Meeting of the American Society for Bone and Mineral Research; August 1996. [abstract] J Bone Miner Res. 1996 Aug; 11(Suppl 1):S228.

Suit HD, Sedlacek R, Wagner M, Orsi L, Silobrcic V, Rothman KJ. Effect of corynebacterium parvum on the response to irradiation of a c3h fibrosarcoma. Cancer Res. 1976 Apr 1;36(4):1305-14.